Jan 27 (Reuters) - Immutep Ltd (IMM) :
- IMMUTEP - ANNOUNCES ADVANCEMENT OF PHASE II TRIAL FOR EFTILAGIMOD ALPHA IN COVID- 19 PATIENTS
News: IMM Immutep Announces Advancement Of Phase 2 Trial For Eftilagimod Alpha
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.075(25.4%) |
Mkt cap ! $512.0M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 37.5¢ | 33.5¢ | $4.399M | 12.31M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 52599 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 173490 | 7 |
View Market Depth
| Last trade - 11.56am 12/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |